PDF-HLR 9701CDataMy DocumentsNDAs20896SE7010Phase4XelodaTaxotere PI 0907
Author : cora | Published Date : 2021-10-06
XELODA Warfarin Interaction Patients receiving concomitant capecitabine and oral coumarinderivative anticoagulant therapy should have their anticoagulant response
Presentation Embed Code
Download Presentation
Download Presentation The PPT/PDF document "HLR 9701CDataMy DocumentsNDAs20896SE7010..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
HLR 9701CDataMy DocumentsNDAs20896SE7010Phase4XelodaTaxotere PI 0907: Transcript
XELODA Warfarin Interaction Patients receiving concomitant capecitabine and oral coumarinderivative anticoagulant therapy should have their anticoagulant response INR or prothrombin timemonitored fre. 0907 Precinct Approval Date INSTRUCTIONS 1 This is an application NOT a sound device permit 2 All answers must be either typewritten or printed in ink 3 File application in the preci 1R3501,76012,1355525 23508906,1367534 33501,0907,5153918 43506304,3442210 BA1701,74011,99763 LBB1706854,72363 SpecificationsCodeSizeUSMetricRecommendationsNo.No. Deuterium, Research Grade 99.999%* G26
Download Document
Here is the link to download the presentation.
"HLR 9701CDataMy DocumentsNDAs20896SE7010Phase4XelodaTaxotere PI 0907"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.
Related Documents
